American Injectables, founded in 2020, is a CDMO specializing in sterile injectable drug products, operating from its FDA-approved facility in Florida. The company prides itself on speed, flexibility, and quality, offering tailored services from formulation to final product realization for both U.S. and global markets.
Targeting the Manufacturing and Pharmaceutical sectors, American Injectables stands out with its ability to create flexible partnerships, addressing clients' needs at various stages of the drug manufacturing lifecycle. This young yet promising entity provides options for companies looking for a dynamic new manufacturing partner.
The company recently secured a $19.00M investment in an Early VC round as of 01 October 2022, signaling confidence from investors in their growth trajectory and commitment to industry excellence. With a focus on innovation and quality, American Injectables is poised to make significant strides in its niche market.